$VKTX just to point out the new situation to bears and bulls alike, new information (CEO statements, public information etc) confirms that the list of buyers interested in weight loss assets continues to grow: ABBV, AMGN, JNJ, MRK, NVO, and even AMZN and HIMS, while the list of late stage clinical weight loss companies continues to shrink (after recent KLRA trial results, it's really only VKTX and GPCR, and GPCR hasn't started p3 yet, while VKTX is less than a year away from completion of P3 AND less than 2 months away from releasing longer term data (33 weeks versus 13 weeks released previously) for its primary asset. If anyone thinks BP won't be interested in VKTX after maintenance results are released, you're certifiably nuts! Long and so insanely
View on X ↗